元大10年IG醫療債
00787B 成交量僅含一般交易、盤後定價交易31.74
0.16 0.51%來看看今天全站最強的持股績效是什麼組合吧！單日＋47.34%！「點我」查看！(盤中即時更新)
元大10年IG醫療債(00787B) ETF持股分布
目前尚無相關資料
債券發行國分布
2026/09/17| 國家 | 比例 |
|---|---|
美國 | 93.66% |
英國 | 2.61% |
日本 | 1.12% |
現金 | 2.61% |
債券持倉明細
2026/09/17發行公司 | 票息率 | 到期日 | 面額 | 市值 | 權重 |
|---|---|---|---|---|---|
CVS HEALTH CORP AR6336036 | 5.05% | 2048/03/25 | 570,000 | 494,407.2 | 4.38% |
AMGEN INC ZL1040761 | 5.65% | 2053/03/02 | 420,000 | 391,361.51 | 3.47% |
ABBVIE INC ZD2443392 | 5.4% | 2054/03/15 | 360,000 | 328,942.44 | 2.92% |
PFIZER INC EH7597287 | 7.2% | 2039/03/15 | 240,000 | 269,558.64 | 2.39% |
ABBOTT LABORATORIES AL3302604 | 4.9% | 2046/11/30 | 230,000 | 206,113.81 | 1.83% |
BRISTOL-MYERS SQUIBB CO ZD0496756 | 5.55% | 2054/02/22 | 210,000 | 195,816.04 | 1.74% |
MERCK & CO INC ZK5382500 | 5% | 2053/05/17 | 210,000 | 185,668.26 | 1.65% |
AMGEN INC ZL1040779 | 5.75% | 2063/03/02 | 200,000 | 185,661.71 | 1.65% |
ABBVIE INC BM0493411 | 4.25% | 2049/11/21 | 230,000 | 181,523.02 | 1.61% |
GILEAD SCIENCES INC ZI8069604 | 5.55% | 2053/10/15 | 180,000 | 173,132.01 | 1.53% |
GLAXOSMITHKLINE CAP INC EH3525340 | 6.375% | 2038/05/15 | 160,000 | 172,351.72 | 1.53% |
BIOGEN INC UV8489444 | 5.2% | 2045/09/15 | 190,000 | 168,933.43 | 1.5% |
ABBOTT LABORATORIES EI2623920 | 5.3% | 2040/05/27 | 160,000 | 157,178.19 | 1.39% |
ABBVIE INC AU5268761 | 4.875% | 2048/11/14 | 180,000 | 157,165.68 | 1.39% |
GILEAD SCIENCES INC EK6007513 | 4.5% | 2045/02/01 | 180,000 | 151,310.7 | 1.34% |
MERCK & CO INC ZK5382583 | 5.15% | 2063/05/17 | 170,000 | 149,443.04 | 1.32% |
CVS HEALTH CORP ZB9548767 | 6.05% | 2054/06/01 | 150,000 | 145,678.79 | 1.29% |
AMGEN INC ZL1040746 | 5.6% | 2043/03/02 | 150,000 | 143,315.38 | 1.27% |
PFIZER INC AL2532367 | 4.125% | 2046/12/15 | 170,000 | 134,498.09 | 1.19% |
THERMO FISHER SCIENTIFIC AO7302802 | 4.1% | 2047/08/15 | 170,000 | 134,011.23 | 1.19% |
CVS HEALTH CORP ZK8345926 | 6% | 2063/06/01 | 140,000 | 132,590.69 | 1.18% |
MEDTRONIC INC UV4493036 | 4.625% | 2045/03/15 | 150,000 | 128,802.36 | 1.14% |
TAKEDA PHARMACEUTICAL BK2963274 | 3.175% | 2050/07/09 | 200,000 | 127,834.28 | 1.13% |
ABBOTT LABORATORIES EH7397175 | 6% | 2039/04/01 | 120,000 | 127,262.08 | 1.13% |
PFIZER INC AX5019291 | 4% | 2049/03/15 | 170,000 | 127,212.76 | 1.13% |
ABBOTT LABORATORIES AM6184619 | 4.75% | 2043/04/15 | 140,000 | 126,380.17 | 1.12% |
NOVARTIS CAPITAL CORP EK0812140 | 4.4% | 2044/05/06 | 140,000 | 119,993.77 | 1.06% |
NOVARTIS CAPITAL CORP QJ8247554 | 4% | 2045/11/20 | 150,000 | 119,925.32 | 1.06% |
ABBVIE INC ZD2443400 | 5.5% | 2064/03/15 | 130,000 | 118,076.18 | 1.05% |
ELI LILLY & CO YV0970363 | 5.2% | 2064/08/14 | 130,000 | 114,342.42 | 1.01% |
JOHNSON & JOHNSON JK2606917 | 3.7% | 2046/03/01 | 150,000 | 114,233.58 | 1.01% |
MERCK & CO INC AX5270746 | 4% | 2049/03/07 | 150,000 | 112,964.73 | 1% |
BAXALTA INC JK9635554 | 5.25% | 2045/06/23 | 122,000 | 111,857.87 | 0.99% |
MERCK & CO INC ZK5382419 | 4.9% | 2044/05/17 | 120,000 | 108,129.05 | 0.96% |
ASTRAZENECA PLC EG8123564 | 6.45% | 2037/09/15 | 100,000 | 106,872.35 | 0.95% |
BRISTOL-MYERS SQUIBB CO BK1099625 | 4.35% | 2047/11/15 | 130,000 | 105,197.89 | 0.93% |
THERMO FISHER SCIENTIFIC ZI2439159 | 5.404% | 2043/08/10 | 110,000 | 104,479.67 | 0.93% |
AMGEN INC AL7020855 | 4.563% | 2048/06/15 | 120,000 | 98,253.57 | 0.87% |
ZOETIS INC EJ8555645 | 4.7% | 2043/02/01 | 110,000 | 94,632.9 | 0.84% |
ASCENSION HEALTH JK9116332 | 3.945% | 2046/11/15 | 120,000 | 93,462.81 | 0.83% |
COMMONSPIRIT HEALTH AZ9084775 | 4.187% | 2049/10/01 | 120,000 | 91,831.08 | 0.81% |
GILEAD SCIENCES INC EK1088500 | 4.8% | 2044/04/01 | 100,000 | 89,624.67 | 0.79% |
ABBVIE INC BM0472837 | 4.85% | 2044/06/15 | 100,000 | 88,668.42 | 0.79% |
ABBVIE INC BM0474270 | 4.75% | 2045/03/15 | 100,000 | 85,941.48 | 0.76% |
GILEAD SCIENCES INC UV8399916 | 4.75% | 2046/03/01 | 100,000 | 85,761.91 | 0.76% |
ABBOTT LABORATORIES EH0073963 | 6.15% | 2037/11/30 | 80,000 | 85,500.56 | 0.76% |
CVS HEALTH CORP ZK8344739 | 5.875% | 2053/06/01 | 90,000 | 85,320.16 | 0.76% |
ASTRAZENECA PLC QJ7515456 | 4.375% | 2045/11/16 | 100,000 | 84,069.94 | 0.75% |
BRISTOL-MYERS SQUIBB CO BU5808946 | 3.7% | 2052/03/15 | 120,000 | 83,377.48 | 0.74% |
BRISTOL-MYERS SQUIBB CO BK1098833 | 5% | 2045/08/15 | 90,000 | 80,010.21 | 0.71% |
CENCORA INC AQ2404269 | 4.3% | 2047/12/15 | 100,000 | 79,511.13 | 0.7% |
NY & PRESBYTERIAN HOSPIT EK7279145 | 4.024% | 2045/08/01 | 100,000 | 79,113.06 | 0.7% |
PFIZER INC EK2708494 | 4.4% | 2044/05/15 | 90,000 | 76,274.94 | 0.68% |
STRYKER CORP JK3460470 | 4.625% | 2046/03/15 | 90,000 | 75,701.83 | 0.67% |
AMGEN INC EI8703171 | 5.15% | 2041/11/15 | 80,000 | 74,088.79 | 0.66% |
BRISTOL-MYERS SQUIBB CO BK1099815 | 4.55% | 2048/02/20 | 90,000 | 73,714.85 | 0.65% |
JOHNSON & JOHNSON EI3551039 | 4.5% | 2040/09/01 | 80,000 | 72,334.24 | 0.64% |
JOHNSON & JOHNSON AP9426390 | 3.5% | 2048/01/15 | 100,000 | 72,321.3 | 0.64% |
CVS HEALTH CORP AF2646764 | 5.125% | 2045/07/20 | 80,000 | 69,871.76 | 0.62% |
TOLEDO HOSPITAL/THE AV1308056 | 5.75% | 2038/11/15 | 70,000 | 69,540.51 | 0.62% |
BRISTOL-MYERS SQUIBB CO BK1131808 | 4.625% | 2044/05/15 | 80,000 | 69,091.93 | 0.61% |
ABBVIE INC EJ7488335 | 4.4% | 2042/11/06 | 80,000 | 68,712.43 | 0.61% |
CVS HEALTH CORP ZB9548718 | 6% | 2044/06/01 | 70,000 | 68,591.9 | 0.61% |
JOHNSON & JOHNSON AM6819156 | 3.75% | 2047/03/03 | 90,000 | 68,181.98 | 0.6% |
BRISTOL-MYERS SQUIBB CO ZD0496749 | 5.5% | 2044/02/22 | 70,000 | 66,801.51 | 0.59% |
ASTRAZENECA PLC EJ3604638 | 4% | 2042/09/18 | 80,000 | 66,407.12 | 0.59% |
COMMONSPIRIT HEALTH BM0687996 | 3.91% | 2050/10/01 | 90,000 | 65,458.54 | 0.58% |
GILEAD SCIENCES INC QZ5802157 | 4.15% | 2047/03/01 | 80,000 | 62,723.26 | 0.56% |
PFIZER INC AU3780957 | 4.2% | 2048/09/15 | 80,000 | 61,816.08 | 0.55% |
JOHNS HOPKINS HEALTH SYS AL1180242 | 3.837% | 2046/05/15 | 80,000 | 61,420.06 | 0.54% |
AMGEN INC BU6367256 | 4.2% | 2052/02/22 | 80,000 | 59,982.67 | 0.53% |
STANFORD HEALTH CARE AQ6802492 | 3.795% | 2048/11/15 | 80,000 | 59,454.9 | 0.53% |
ABBVIE INC ZD2443384 | 5.35% | 2044/03/15 | 60,000 | 56,085.11 | 0.5% |
KAISER FOUNDATION HOSPIT AN3642401 | 4.15% | 2047/05/01 | 70,000 | 55,940.15 | 0.5% |
NORTHWELL HEALTHCARE INC AP1549447 | 4.26% | 2047/11/01 | 70,000 | 55,330.22 | 0.49% |
NOVARTIS CAPITAL CORP BG0200108 | 2.75% | 2050/08/14 | 90,000 | 54,488.27 | 0.48% |
JOHNSON & JOHNSON EJ9701586 | 4.5% | 2043/12/05 | 60,000 | 54,126.3 | 0.48% |
KAISER FOUNDATION HOSPIT ZQ3047169 | 3.266% | 2049/11/01 | 80,000 | 53,466.4 | 0.47% |
ELI LILLY & CO ZF9004630 | 5.1% | 2064/02/09 | 60,000 | 51,978.72 | 0.46% |
NOVANT HEALTH INC BP0156367 | 3.168% | 2051/11/01 | 80,000 | 51,317.76 | 0.45% |
BECTON DICKINSON & CO EK6433974 | 4.685% | 2044/12/15 | 60,000 | 51,185.82 | 0.45% |
ABBVIE INC LW0654365 | 4.45% | 2046/05/14 | 60,000 | 50,019.59 | 0.44% |
GILEAD SCIENCES INC EI9011251 | 5.65% | 2041/12/01 | 50,000 | 49,807.1 | 0.44% |
MERCK & CO INC EJ6801066 | 4.15% | 2043/05/18 | 60,000 | 49,630.28 | 0.44% |
AMGEN INC AL7020905 | 4.663% | 2051/06/15 | 60,000 | 49,175.29 | 0.44% |
NOVARTIS CAPITAL CORP EJ3705658 | 3.7% | 2042/09/21 | 60,000 | 48,296.86 | 0.43% |
JOHNSON & JOHNSON YX0780362 | 5.25% | 2054/06/01 | 50,000 | 47,951.81 | 0.43% |
CVS HEALTH CORP EJ9701040 | 5.3% | 2043/12/05 | 50,000 | 45,569.29 | 0.4% |
MEMORIAL SLOAN-KETTERING EK7389019 | 4.2% | 2055/07/01 | 60,000 | 45,122.42 | 0.4% |
ELI LILLY & CO YV0970322 | 5.05% | 2054/08/14 | 50,000 | 44,165.82 | 0.39% |
MERCK & CO INC BS9042729 | 2.9% | 2061/12/10 | 80,000 | 44,152.28 | 0.39% |
ELI LILLY & CO AX3340830 | 4.15% | 2059/03/15 | 60,000 | 44,148.35 | 0.39% |
ELI LILLY & CO ZF9004606 | 5% | 2054/02/09 | 50,000 | 43,902.93 | 0.39% |
LABORATORY CORP OF AMER EK7126486 | 4.7% | 2045/02/01 | 50,000 | 43,276.76 | 0.38% |
BAYLOR SCOTT & WHITE HOL BN5399314 | 2.839% | 2050/11/15 | 70,000 | 42,808.56 | 0.38% |
ABBVIE INC BM0491613 | 4.05% | 2039/11/21 | 50,000 | 42,748.33 | 0.38% |
GLAXOSMITHKLINE CAP INC EJ5929876 | 4.2% | 2043/03/18 | 50,000 | 42,206.8 | 0.37% |
JOHNSON & JOHNSON AP9424510 | 3.4% | 2038/01/15 | 50,000 | 42,104 | 0.37% |
WYETH LLC EG2993269 | 5.95% | 2037/04/01 | 40,000 | 41,932.26 | 0.37% |
BAPTIST HEALTHCARE ZO9414202 | 3.54% | 2050/08/15 | 60,000 | 40,895.88 | 0.36% |
BRISTOL-MYERS SQUIBB CO BU5808953 | 3.9% | 2062/03/15 | 60,000 | 40,786.56 | 0.36% |
ASTRAZENECA PLC AU0580426 | 4.375% | 2048/08/17 | 50,000 | 40,744.17 | 0.36% |
NYU LANGONE HOSPITALS ZP7436709 | 3.38% | 2055/07/01 | 60,000 | 38,723.49 | 0.34% |
JOHNSON & JOHNSON ZO1044189 | 2.25% | 2050/09/01 | 70,000 | 38,382.02 | 0.34% |
MERCK & CO INC EK7402309 | 3.7% | 2045/02/10 | 50,000 | 37,663.23 | 0.33% |
AMGEN INC BG1438434 | 3.15% | 2040/02/21 | 50,000 | 37,438.98 | 0.33% |
MASS GENERAL BRIGHAM INC ZP6454703 | 3.342% | 2060/07/01 | 60,000 | 37,337.47 | 0.33% |
ZOETIS INC AP0341945 | 3.95% | 2047/09/12 | 50,000 | 37,165.97 | 0.33% |
AMGEN INC BU6349619 | 4.4% | 2062/02/22 | 50,000 | 37,050.54 | 0.33% |
KAISER FOUNDATION HOSPIT EJ1047483 | 4.875% | 2042/04/01 | 40,000 | 37,026.74 | 0.33% |
CVS HEALTH CORP ZL0458204 | 5.625% | 2053/02/21 | 40,000 | 36,144.43 | 0.32% |
ABBVIE INC EK8976012 | 4.7% | 2045/05/14 | 40,000 | 34,719.72 | 0.31% |
ELI LILLY & CO ZL2713820 | 4.875% | 2053/02/27 | 40,000 | 34,395.63 | 0.3% |
HACKENSACK MERIDIAN HLTH ZO0916205 | 2.675% | 2041/09/01 | 50,000 | 34,228.16 | 0.3% |
BOSTON SCIENTIFIC CORP AX3600209 | 4.7% | 2049/03/01 | 40,000 | 33,868.14 | 0.3% |
ELI LILLY & CO ZL2713838 | 4.95% | 2063/02/27 | 40,000 | 33,773.42 | 0.3% |
AMGEN INC BY4591073 | 4.875% | 2053/03/01 | 40,000 | 33,276.16 | 0.29% |
NY & PRESBYTERIAN HOSPIT ZQ2338197 | 3.954% | 2119/08/01 | 50,000 | 32,968.21 | 0.29% |
COTTAGE HEALTH SYSTEM ZP6189903 | 3.304% | 2049/11/01 | 50,000 | 32,964.88 | 0.29% |
ELI LILLY & CO BJ1253712 | 2.25% | 2050/05/15 | 60,000 | 32,729.01 | 0.29% |
BIOGEN INC BJ1478392 | 3.15% | 2050/05/01 | 50,000 | 31,659.08 | 0.28% |
ELI LILLY & CO ZO1044759 | 2.5% | 2060/09/15 | 60,000 | 30,526.7 | 0.27% |
HACKENSACK MERIDIAN HLTH ZO0916015 | 2.875% | 2050/09/01 | 50,000 | 30,462.68 | 0.27% |
MERCK & CO INC BS9042604 | 2.75% | 2051/12/10 | 50,000 | 29,483.26 | 0.26% |
ABBOTT LABORATORIES AL3302596 | 4.75% | 2036/11/30 | 30,000 | 28,647.69 | 0.25% |
JOHNSON & JOHNSON ZO1044197 | 2.45% | 2060/09/01 | 50,000 | 25,555.85 | 0.23% |
BIOGEN INC BW8737346 | 3.25% | 2051/02/15 | 40,000 | 25,254.25 | 0.22% |
CENCORA INC EK7593875 | 4.25% | 2045/03/01 | 30,000 | 23,943.54 | 0.21% |
AMGEN INC EK8864390 | 4.4% | 2045/05/01 | 20,000 | 16,562.59 | 0.15% |
KAISER FOUNDATION HOSPIT BP9878243 | 3.002% | 2051/06/01 | 20,000 | 12,512.51 | 0.11% |
其他資產
| 項目 | 金額 |
|---|---|
| 現金 | NTD1,015,860 |
| 現金 | USD117,858.53 |
| 應收利息 | USD129,036.74 |
| 應付受益權單位買回款 | NTD-15,915,494 |
補充說明
＊ETF並非單一股票或單一債券組合而成，而是一籃子投資標組合而成的，ETF成分股決定了ETF的價值，對於想要以低成本進行資產配置的投資人而言，深入了解基金組合比例是偏重股票、期貨、債券，再進一步分析股票型的產業分布、持股明細和持股權重比例，可掌握到底是哪些成分股的表現影響ETF成長或衰退，也可以在ETF選股時，盡可能避免購買單支成分股權重過高的ETF，較容易使投資風險過於集中。
主動式ETF，是一種基金經理人基於特定投資目標與策略，主動建構投資組合，並進行操作、調整，期能超越大盤指數等績效指標或達到特定投資目標，並在證券交易所上市交易的開放式基金。
資料來源：本站 ETF 持股分布資料來源為各投信公司官方網站、臺灣證券交易所及中華民國證券櫃檯買賣中心公開揭露之申購買回清單（PCF）與相關公告，於每個交易日收盤後彙整更新。部分資料因各投信公告時間不同，實際更新時間可能有所差異。
免責聲明：本站所有資料及分析內容僅供參考，不構成任何投資建議、要約或買賣依據。資料如有延遲、遺漏、錯誤或與各投信公司官方公告不符，一律以各投信公司官方網站公告為準。本站對因資料不完整或錯誤所導致之損失，不負任何法律責任。投資人應審慎評估自身風險承受能力，並自行承擔一切投資損益。
